by Anthony Spagnoli | Jul 14, 2025 | Studies
GI bleeding is the most common GI condition necessitating hospital admission in the United States, accounting for over 500,000 admissions in 2014.1 EGD is the first-line diagnostic and therapeutic modality for patients with upper GI bleeding. However, timely EGD...
by Anthony Spagnoli | Jul 14, 2025 | Studies
Introduction Gastrointestinal bleeding is a common emergent condition, accounting for 7% to 8% of acute medical admissions. In the United States, upper GI bleeding (UGIB) leads to an average of 300,000 admissions per year and has a mortality rate that ranges from 2%...
by Anthony Spagnoli | Jul 14, 2025 | Studies
A novel blood-sensing capsule for rapid detection of upper GI bleeding: a prospective clinical trial. Background and Aims Upper GI bleeding (UGIB) is a common medical emergency associated with high resource utilization, morbidity, and mortality. Timely EGD can be...
by Anthony Spagnoli | Dec 29, 2020 | Business
Courtesy Charlie Taylor – Irish Times Jan 09, 2019 EnteraSense, a Galway-based medical technology start-up has secured €3.5 million in funding through a combination of private seed investment and an EU Horizon 2020 grant.Founded in 2015, the company has licensed a...
by Anthony Spagnoli | Dec 22, 2020 | Business, Featured
Courtesy Dearbhail McDonald – Irish Independent Jan 07, 2019An Irish medtech startup that has developed a capsule that can detect bleeding in the gastrointestinal tract has received backing from the European Union Horizon 2020 grant programme.Galway-based EnteraSense,...
